Concord Biotech Ltd vs Mangalam Drugs And Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Concord Biotech Ltd is ₹ 1184 as of 05 May 15:30 . The P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Mangalam Drugs and Organics Ltd changed from 17.5 on March 2025 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 years The Market Cap of Concord Biotech Ltd changed from ₹ 15922 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Mangalam Drugs and Organics Ltd changed from ₹ 146.65 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Concord Biotech Ltd for the Dec '25 is ₹ 287.74 crore as compare to the Sep '25 revenue of ₹ 262.7 crore. This represent the growth of 9.53% The revenue of Mangalam Drugs and Organics Ltd for the Dec '25 is ₹ 58.6 crore as compare to the Sep '25 revenue of ₹ 49.57 crore. This represent the growth of 18.22% The ebitda of Concord Biotech Ltd for the Dec '25 is ₹ 104.98 crore as compare to the Sep '25 ebitda of ₹ 104.13 crore. This represent the growth of 0.82% The ebitda of Mangalam Drugs and Organics Ltd for the Dec '25 is ₹ -1.32 crore as compare to the Sep '25 ebitda of ₹ -2.81 crore. This represent the decline of -53.02% The net profit of Concord Biotech Ltd changed from ₹ 59.59 crore to ₹ 63.64 crore over 7 quarters. This represents a CAGR of 3.83% The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 2.68 crore to ₹ -9.84 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Concord Biotech Ltd changed from 2.73 % on March 2022 to 24.54 % on March 2025 . This represents a CAGR of 73.15% over 4 yearsThe Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Concord Biotech Ltd

Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
The company was promoted by Dhoot family.
The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

FAQs for the comparison of Concord Biotech Ltd and Mangalam Drugs and Organics Ltd

Which company has a larger market capitalization, Concord Biotech Ltd or Mangalam Drugs and Organics Ltd?

Market cap of Concord Biotech Ltd is 12,502 Cr while Market cap of Mangalam Drugs and Organics Ltd is 48 Cr

What are the key factors driving the stock performance of Concord Biotech Ltd and Mangalam Drugs and Organics Ltd?

The stock performance of Concord Biotech Ltd and Mangalam Drugs and Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Concord Biotech Ltd and Mangalam Drugs and Organics Ltd?

As of May 5, 2026, the Concord Biotech Ltd stock price is INR ₹1195.1. On the other hand, Mangalam Drugs and Organics Ltd stock price is INR ₹30.66.

How do dividend payouts of Concord Biotech Ltd and Mangalam Drugs and Organics Ltd compare?

To compare the dividend payouts of Concord Biotech Ltd and Mangalam Drugs and Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.